Diagnostic Approaches in Myeloid Sarcoma

Elżbieta Patkowska(Institute for Transfusion Medicine), Monika Prochorec‐Sobieszek(Instytut Hematologii i Transfuzjologi), Magdalena Wojtas(Instytut Hematologii i Transfuzjologi), Agnieszka Krzywdzińska(Instytut Hematologii i Transfuzjologi), Iwona Solarska(Instytut Hematologii i Transfuzjologi)

Current Issues in Molecular Biology

February 10, 2025

10.3390/cimb47020111

Cited by 11

Related Papers

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2023|390

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy

|Blood|2022|129

SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism

|Cell Death and Disease|2020|41

Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia

|Molecular Oncology|2019|37

Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment

|Polskie Archiwum Medycyny Wewnętrznej|2022|37